Cargando…
COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790762/ https://www.ncbi.nlm.nih.gov/pubmed/36567408 http://dx.doi.org/10.1007/s10072-022-06584-w |
| _version_ | 1784859252107509760 |
|---|---|
| author | Trinchillo, Assunta Esposito, Marcello Habetswallner, Francesco Tuccillo, Francesco De Martino, Bernardo Maria |
| author_facet | Trinchillo, Assunta Esposito, Marcello Habetswallner, Francesco Tuccillo, Francesco De Martino, Bernardo Maria |
| author_sort | Trinchillo, Assunta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9790762 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97907622022-12-27 COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation Trinchillo, Assunta Esposito, Marcello Habetswallner, Francesco Tuccillo, Francesco De Martino, Bernardo Maria Neurol Sci Covid-19 Springer International Publishing 2022-12-25 2023 /pmc/articles/PMC9790762/ /pubmed/36567408 http://dx.doi.org/10.1007/s10072-022-06584-w Text en © Fondazione Società Italiana di Neurologia 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Covid-19 Trinchillo, Assunta Esposito, Marcello Habetswallner, Francesco Tuccillo, Francesco De Martino, Bernardo Maria COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation |
| title | COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation |
| title_full | COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation |
| title_fullStr | COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation |
| title_full_unstemmed | COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation |
| title_short | COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation |
| title_sort | covid19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation |
| topic | Covid-19 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790762/ https://www.ncbi.nlm.nih.gov/pubmed/36567408 http://dx.doi.org/10.1007/s10072-022-06584-w |
| work_keys_str_mv | AT trinchilloassunta covid19vaccineinmyastheniagravispatientssafetyandpossiblepredictorsofdiseaseexacerbation AT espositomarcello covid19vaccineinmyastheniagravispatientssafetyandpossiblepredictorsofdiseaseexacerbation AT habetswallnerfrancesco covid19vaccineinmyastheniagravispatientssafetyandpossiblepredictorsofdiseaseexacerbation AT tuccillofrancesco covid19vaccineinmyastheniagravispatientssafetyandpossiblepredictorsofdiseaseexacerbation AT demartinobernardomaria covid19vaccineinmyastheniagravispatientssafetyandpossiblepredictorsofdiseaseexacerbation |